Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Regulation of Laloo by the Xenopus C-terminal Src kinase (Xcsk) during early vertebrate development

Abstract

Mesoderm formation in the frog, Xenopus laevis, is dependent on the activity of one or more members of the Src family kinases; the molecular interactions underlying this requirement are not well understood. The C-terminal Src Kinase (Csk) is a potent inhibitor of Src activity, and is required for normal mammalian development; here we report the characterization of Xenopus Csk (Xcsk). Xcsk is widely expressed during early development, physically interacts with the Src kinase Laloo, and inhibits the generation of mesoderm by the Src kinases. Xcsk activity requires a functional kinase domain; furthermore, a kinase-inactive Xcsk mutant potently synergizes with Laloo during early vertebrate development, suggesting a fundamental role for the Src kinase-Csk regulatory circuit during mesoderm induction, in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bassez T, Paris J, Omilli F, Dorel C, Osborne HB . 1990 Development 110: 955–962

  • Brown MT, Cooper JA . 1996 Biochim. Biophys. Acta. 1287: 121–149

  • Christian JL, McMahon JA, McMahon AP, Moon RT . 1991 Development 111: 1045–1055

  • Chow LM, Fournel M, Davidson D, Veillette A . 1993 Nature 365: 156–160

  • Curran KL, Grainger RM . 2000 Dev. Biol. 228: 41–56

  • Hemmati-Brivanlou A, Melton DA . 1994 Cell 77: 273–281

  • Honda Z, Suzuki T, Hirose N, Aihara M, Shimizu T, Nada S, Okada M, Ra C, Morita Y, Ito K . 1997 J. Biol. Chem. 272: 25753–25760

  • Imamoto A, Soriano P . 1993 Cell 73: 1117–1124

  • Krieg P, Varnum S, Wormington M, Melton DA . 1989 Dev. Biol. 133: 93–100

  • LaBonne C, Whitman M . 1997 Dev. Biol. 183: 9–20

  • Miller MA, Malik IA, Shenk MA, Steele RE . 2000 Oncogene 19: 3925–3930

  • Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H . 1991 Nature 351: 69–72

  • Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y, Okada M, Aizawa S . 1993 Cell 73: 1125–1135

  • Sasai Y, Lu B, Steinbeisser H, Geissert D, Gont LK, DeRobertis EM . 1994 Cell 79: 779–790

  • Smith JC, Price BMJ, Green JBA, Weigel D, Herrmann BG . 1991 Cell 67: 79–87

  • Smith WC, Harland RM . 1991 Cell 67: 753–765

  • Steele RE, Deng JC, Ghosn CR, Fero JB . 1990 Oncogene 5: 369–376

  • Takeuchi M, Kuramochi S, Fusaki N, Nada S, Kawamura-Tsuzuku J, Matsuda S, Semba K, Toyoshima K, Okada M, Yamamoto T . 1993 J. Biol. Chem. 268: 27413–27419

  • Weinstein DC, Hemmati-Brivanlou A . 2001 Dev. Dyn. 220: 163–168

  • Weinstein DC, Marden J, Carnevali F, Hemmati-Brivanlou A . 1998 Nature 394: 904–908

  • Wilson PA, Hemmati-Brivanlou A . 1995 Nature 376: 331–333

Download references

Acknowledgements

The authors thank D Morgan for the gift of Xcsk, R Steele for Xfyn, and J Hama and P Wilson for critical reading of the manuscript. D Weinstein is supported by an Irma T Hirschl Career Scientist Award, by the Speaker's Fund for Biomedical Research: Toward the Science of Patient Care, awarded by the City of New York, and by the AMDeC Foundation of New York City, through its ‘Tartikoff/Perelman/EIF Fund for Young Investigators in Women's Cancers’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel C Weinstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, Y., Cohler, A. & Weinstein, D. Regulation of Laloo by the Xenopus C-terminal Src kinase (Xcsk) during early vertebrate development. Oncogene 20, 5210–5214 (2001). https://doi.org/10.1038/sj.onc.1204672

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204672

Keywords

Search

Quick links